GENERIC NAME OF THE MEDICINAL PRODUCT:

1. Daclatasvir Dihydrochloride Tablets 60mg (DAKLITAJ)
2. Daclatasvir Dihydrochloride Tablets 30mg (DAKLITAJ)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Daclatasvir Dihydrochloride Tablets 60mg
Each film-coated tablet contains:
Daclatasvir Dihydrochloride IP
Eq. to Daclatasvir……………60mg
Excipients…………………………q.s.
Color: Titanium Dioxide IP


2. Daclatasvir Dihydrochloride Tablets 30mg
Each film-coated tablet contains:
Daclatasvir Dihydrochloride IP
Eq. to Daclatasvir……………30mg
Excipients…………………………q.s.
Color: Lake of Indigo Carmine

THERAPEUTIC INDICATIONS:

Daclatasvir is used to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors

CAUTION & SCHEDULE:

CAUTION: Do not use if seal over bottle opening is broken or missing.
Dispense in a tight, light-resistance, container.
Keep store in tightly closed container.
DO NOT BREAK OR CRUSH TABLET.
SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: To be sold by retail on the prescription of a “Hepatologist Only”.

STORAGE & DOSAGE:

STORAGE: Protect from Light & moisture at temperature not exceeding 30°C. Keep in cool & Dry place.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Read enclosed leaflet before use.
DOSAGE: AS DIRECTED BY THE HEPATOLOGIST.

Daclatasvir Dihydrochloride Tablets 60mg Technical Specification:

Product Name: Daclatasvir Dihydrochloride Tablets
Brand Name: DAKLITAJ
Strength: 60mg, 30mg
Dosage Form: Film-coated Oral Tablets
Route of Administration: Via Oral Route
Packing: 28s
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Hepatitis C Treatment
Indication: Daclatasvir is used to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors
Storage: Protect from Light & moisture at temperature not exceeding 30°C. Keep in cool & Dry place.

GENERIC NAME OF THE MEDICINAL PRODUCT:

1. Daclatasvir Dihydrochloride Tablets 60mg (DAKLITAJ)
2. Daclatasvir Dihydrochloride Tablets 30mg (DAKLITAJ)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Daclatasvir Dihydrochloride Tablets 60mg
Each film-coated tablet contains:

Daclatasvir Dihydrochloride IP
Eq. to Daclatasvir……………60mg
Excipients…………………………q.s.
Color: Titanium Dioxide IP

2. Daclatasvir Dihydrochloride Tablets 30mg (DAKLITAJ)
Each film-coated tablet contains:
Daclatasvir Dihydrochloride IP
Eq. to Daclatasvir……………30mg
Excipients…………………………q.s.
Color:Lake of Indigo Carmine

THERAPEUTIC INDICATIONS:

Daclatasvir is used to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors

CAUTION & SCHEDULE:

CAUTION: Do not use if seal over bottle opening is broken or missing.
Dispense in a tight, light-resistance, container.
Keep store in tightly closed container.
DO NOT BREAK OR CRUSH TABLET.

SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: To be sold by retail on the prescription of a “Hepatologist Only”.

STORAGE & DOSAGE:

STORAGE: Protect from Light & moisture at temperature not exceeding 30°C. Keep in cool & Dry place.
Keep medicine out of reach of children.
Read enclosed leaflet before use.

Dosage: AS DIRECTED BY THE HEPATOLOGIST.

Introduction to Daclatasvir Dihydrochloride Tablets 60mg (DAKLITAJ)

Daclatasvir Dihydrochloride Tablets 60mg, marketed under the brand DAKLITAJ, is a vital antiviral medication used to treat chronic Hepatitis C. It belongs to the class of HCV NS5A inhibitors, which blocks viral replication and improves liver health.

✔ Therapeutic Uses

  • Treats chronic Hepatitis C infections in adults

  • Used in combination with Sofosbuvir or other antivirals

  • Reduces liver inflammation and prevents fibrosis

  • Helps achieve sustained virologic response (SVR)

  • Prevents progression to cirrhosis or liver cancer

✔ Global Demand

The global need for Daclatasvir 60mg tablets is significant due to rising Hepatitis C prevalence in Africa, Southeast Asia, the Middle East, and Latin America. India is a primary supplier for regulated and semi-regulated markets, offering affordable, high-quality antiviral solutions.

Taj Pharma meets this demand by supplying premium DAKLITAJ 60mg tablets to hospitals, pharmacies, government tenders, and NGOs worldwide.


 In-Depth Details for Importers, Exporters, and Buyers

Taj Pharma provides comprehensive support to global buyers, ensuring hassle-free importation, regulatory compliance, and secure shipping.


  ✔ Regulatory Documentation Provided

Taj Pharma offers all necessary documentation to facilitate imports:

  • WHO-GMP Certificate

  • EU-GMP Certificate (for select markets)

  • COPP (Certificate of Pharmaceutical Product)

  • CTD / ACTD Dossier

  • COA (Certificate of Analysis) for each batch

  • Stability study reports

  • Free Sale Certificate

  • GMP Audit Reports

  • Packaging material certification

This ensures regulatory approval and smooth customs clearance in target countries.

 ✔ Custom Packaging & Labeling

Global buyers can avail:

  • Multilingual labeling

  • Hospital/NGO specific packaging

  • Anti-counterfeit coding

  • Blister packs or bottles

  • Custom artwork with barcodes

Taj Pharma ensures packaging meets both regulatory and client requirements.

  ✔ Shelf-Life, Storage & Dosage Form

  • Shelf-life: 24–36 months

  • Dosage Form: Film-coated tablets

  • Strength: 60 mg Daclatasvir Dihydrochloride

  • Packaging: 14-tablet, 28-tablet, or bulk packs

  • Storage: Store below 30°C, away from moisture and light


  ✔ Export Certifications

Taj Pharma’s facilities and products are certified by:

  • WHO-GMP (World Health Organization – Good Manufacturing Practices)

  • EU-GMP (European Good Manufacturing Practice)

  • ISO 9001:2015 (Quality Management System)

  • ISO 14001:2015 (Environmental Management System)

  • OHSAS 18001 (Occupational Health & Safety)

This guarantees acceptance in both regulated and semi-regulated markets worldwide.


 ✔ Target Countries & Export Markets

Taj Pharma exports DAKLITAJ 60mg to:

  • Africa (Nigeria, Kenya, Tanzania, Uganda, South Africa)

  • Middle East (UAE, Iraq, Yemen)

  • Southeast Asia (Vietnam, Philippines, Myanmar, Cambodia)

  • Latin America (Peru, Bolivia, Ecuador, Dominican Republic)

  • CIS countries (Kazakhstan, Ukraine, Uzbekistan)

They also participate in government and NGO tenders globally.


 Why Taj Pharma is the Most Trusted Manufacturer/Supplier/Exporter

✔ State-of-the-Art Manufacturing

  • WHO-GMP-compliant production lines

  • Advanced quality control laboratories

  • API to finished dosage integration

  • Multi-level quality assurance

✔ Affordable Pricing & Quality Assurance

Taj Pharma balances cost-effectiveness with premium quality, making it ideal for bulk procurement, government tenders, and PCD franchise partners.

✔ Global Presence & Supply Chain Support

  • On-time delivery to 72+ countries

  • Full export documentation support

  • Logistics for air and sea shipments

  • Secure packaging to avoid damage

✔ Top 20 Export Countries

Nigeria | Kenya | Ghana | Tanzania | Uganda | Myanmar | Vietnam | Philippines | Yemen | Afghanistan | Iraq | Iran | Peru | Bolivia | Chile | Mexico | Dominican Republic | Nepal | Cambodia |Ethiopia


 Technical Product Specification Table

Parameter Details
Product Name Daclatasvir Dihydrochloride Tablets 60mg (DAKLITAJ)
Strength 60 mg
Form Film-coated tablet
Pack Size 14 / 28 Tablets
Therapeutic Class Hepatitis C Antiviral
Pharmacological Class HCV NS5A Inhibitor
Manufacturer Taj Pharma, Vapi, Gujarat, India
Shelf-Life 24–36 Months
Certification WHO-GMP, COPP, ISO
Storage Condition Below 30°C, dry place
Usage Chronic Hepatitis C Treatment
Export Availability Worldwide

  Call to Action 

Looking for a reliable Daclatasvir Dihydrochloride Tablets 60mg (DAKLITAJ) Manufacturer, Supplier or Exporter in India?

Taj Pharma is ready to provide premium quality tablets, regulatory support, competitive pricing, and on-time delivery worldwide.

📩 Email: info@tajpharma.com
🌐 Website: www.tajpharma.com
📦 For Export, Wholesale, or PCD Franchise: Contact the International Business Division


 Top 20 FAQs 

  1. What is Daclatasvir Dihydrochloride Tablets 60mg used for?
    Treats chronic Hepatitis C infection.

  2. Is it safe?
    Yes, well-tolerated with minimal side effects.

  3. Common side effects?
    Fatigue, headache, nausea, diarrhea.

  4. Can it be taken alone?
    No. It is used in combination therapy.

  5. Who manufactures DAKLITAJ in India?
    Taj Pharma, Vapi, Gujarat.

  6. Certifications provided?
    WHO-GMP, ISO, COPP, EU-GMP.

  7. Shelf life?
    24–36 months.

  8. Packing size?
    14 or 28 tablets.

  9. PCD franchise available?
    Yes, PAN India.

  10. Supply for government tenders?
    Yes, worldwide.

  11. CTD dossier available?
    Yes.

  12. Custom labels?
    Multilingual packaging available.

  13. Export to Africa possible?
    Yes, widely exported.

  14. Dosage?
    60 mg once daily with companion antivirals.

  15. Onset of action?
    Viral suppression begins in weeks.

  16. Pregnancy safe?
    Only under medical supervision.

  17. Freight support?
    Air/sea shipments available.

  18. COA included?
    Yes, batch-wise.

  19. API supply?
    Available.

  20. Bulk order process?
    Contact export team via email.

Taj Pharma stands as the 1 Daclatasvir Dihydrochloride Tablets 60mg (DAKLITAJ) manufacturer in India, offering high-quality antiviral solutions for global markets. With WHO-GMP compliance, regulatory documentation, competitive pricing, and worldwide delivery, Taj Pharma remains the trusted choice for importers, distributors, hospitals, NGOs, and PCD franchise partners.